Rheumatoid Factor News Today

– ARCALYST® 2023 net product revenue grew ~90% year-over-year to $233.1 million – – ARCALYST 2024 net product revenue expected to be $360 - $380 million – – Abiprubart Phase 2...

The Life Science division of Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today the launch of two new immunoassay interference blockers, K-Block™, and Mouse-Free IgG.

/PRNewswire/ -- The "Autoimmune Disease Diagnostics Market by Product (Reagents, Kits, Assays, Instruments), Test Type (ANA, CRP, ESR, Rheumatoid Factor,...

Treatment for arthritis focuses on relieving symptoms and improving joint function. One may end up trying several medications. The following can be used:

/PRNewswire/ -- The Life Science division of Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw...

Most parents when told that their child has arthritis find it hard to believe it, as arthritis is regarded an adults disease.

Risks are increased, and assessment remains challenging

Rheumatological conditions/autoimmune diseases have been increasing at an alarming rate, early detection can help arrest disease progression and prevent complications. The Department of Rheumatology & Clinical Immunology at Sri Ramakrishna Hospital provides an in-depth look into various rheumatological conditions and the signs to look for to make an early diagnosis.

Oncimmune Holdings Collaboration demonstrates the utility of autoantibodies in Methotrexate and Tocilizumab treatment selection 7:15 am Oncimmune Holdings plc (LON:ONC), the leading global immunodiagnostics group, has announced the publication by PLOS ONE of a study, supported by the Oncimmune’s ImmunoINSIGHTS team, which analysed autoantibodies in patients with newly diagnosed Rheumatoid Arthritis (RA) who were treated with either Tocilizumab or Methotrexate monotherapy. Thi...

Look at these joints. this is where rheumatoid arthritis usually starts, in these knuckles. it can be any joint in the body and affects many major organs. we have disease modifying acts which literally cut down on inflammation. we have necrosis factor drugs. weve made tremendous advances. 1.34 million people have this disease and as david mentioned, decreasing weight, increasing exercise and losing weight is so important but you have to have a top rheumatologist. >> so dont ignore it. >> check t...